The authors develop a novel computational algorithm that identified two signatures of differential response to platinum-based and taxane chemotherapies in breast cancer.
[doi:10.25345/C5VZ8Z]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: novel algorithm ; differential response ; breast cancer ; patient derived xenograft ; taxane cehmotherapy ; platinum-based chemotherapy
|
Principal Investigators: (in alphabetical order) |
Michael T. Lewis, Baylor College of Medicine, United States of America |
| Submitting User: | ramsrinivasan |
Petrosyan V, Dobrolecki LE, LaPlante EL, Srinivasan RR, Bailey MH, Welm AL, Welm BE, Lewis MT, Milosavljevic A.
Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.
NPJ Breast Cancer. 2022 Sep 10;8(1):104. Epub 2022 Sep 10.
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|